Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Yao Y 

PROVIDER: S-EPMC10950817 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature